08
Nov
2012
Marketing approval for STEEN Solution™ in Canada
XVIVO Perfusion receives marketing approval for STEEN Solution™ in Canada. The current main focus for XVIVO Perfusion is…
Read moreNews - Page 8
23
Oct
2012
Technical Note – PERFADEX® with THAM Solution
For our customers in North America we would like to clarify that our product PERFADEX® with THAM Solution is NOT…
Read more
04
Oct
2012
News – Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
Shares in Xvivo Perfusion AB will begin trading on NASDAQ OMX First North on October 8, 2012
Read more
24
Sep
2012
Information regarding the distribution of Xvivo Perfusion AB
In accordance with the resolution adopted by the Extraordinary General Meeting of shareholders held on September 24, Vitrolife’s…
Read more
10
Jul
2012
Application for market approval of STEEN SolutionTM in the USA has been submitted to the FDA
Vitrolife has submitted an application to the American Food and Drug Administration (FDA) regarding market approval of STEEN…
Read more